Merck KGaA sees gain in adj EBITDA of up to 18.5 pct

May 19, 2016 5:21 AM

26 0

FRANKFURT May 19 German drugs and chemicals maker Merck KGaA expects adjusted core earnings to increase by up to 18.5 percent this year, helped by additional profit from a takeover of lab supplies maker Sigma-Aldrich.

Merck forecast full-year earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items, to rise to between 4.1 billion euros ($4.6 billion) and 4.3 billion euros, up from 3.63 billion in 2015.

Also read: Chipmaker SK Hynix reports 64 percent jump in 1Q earnings

Read more

To category page